Quantcast

Latest Cystic Fibrosis Foundation Stories

2012-04-05 23:01:07

Philadelphia area Cystic Fibrosis fundraiser Emily's Entourage has had a successful t-shirt fundraiser yielding both money and awareness for the Cystic Fibrosis Foundation through the sale of custom t-shirts by US screen printers, Rush Order Tees. Rush Order Tees printed the t-shirts for fundraising and promoted their availability through social media in coordination with the non-profit charitable organization Emily´s Entourage. Philadelhpia, PA (PRWEB) April 05, 2012 The Cystic...

2012-03-12 14:31:32

New research could provide roadmap for more effective drug discovery for CF A recent study led by Gergely Lukacs, a professor at McGill University's Faculty of Medicine, Department of Physiology, and published in the January issue of Cell, has shown that restoring normal function to the mutant gene product responsible for cystic fibrosis (CF) requires correcting two distinct structural defects. This finding could point to more effective therapeutic strategies for CF in the future. CF, a...

2011-11-04 12:42:03

Final stage clinical trial shows significantly improved lung function in subset of CF patients A new study has confirmed that the drug, ivacaftor (VX-770), significantly improves lung function in some people with cystic fibrosis (CF). The results of the phase III clinical trial study, "A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation," led by Bonnie W. Ramsey, MD of Seattle Children's Research Institute and the University of Washington, were published today in the...

2011-11-04 10:17:16

Case Western Reserve University School of Medicine, UH Rainbow Babies and Children's Hospital researcher co-authors major clinical trial Results of the pivotal Phase 3 clinical trial published in the Nov. 3, 2011 (embargoed 5 pm ET, Nov. 2, '11) New England Journal of Medicine, find that the oral medication ivacaftor (VX-770) provides major, sustained improvement in lung function, growth and other signs and symptoms for cystic fibrosis (CF) patients. The multi-site study marks the first...

2011-10-10 07:00:00

Agile Sciences will collaborate with Dr. Richard Boucher, Director of the Cystic Fibrosis Center at the University of North Carolina, Chapel Hill Raleigh, NC (PRWEB) October 10, 2011 The National Institutes of Health (NIH) has awarded Agile Sciences a Phase I STTR Grant to evaluate the efficacy of Agile Sciencesâ proprietary Agilyteâ“ž¢ anti-biofilm molecules for treating lung infections of cystic fibrosis patients. The molecules will be tested in...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related